CAPRA 2024 Pharmaceutical SYMPOSIUM Post Event

CAPRA 2024 Pharmaceutical SYMPOSIUM PRESENTATIONS & MATERIALS

Welcome to the official collection of presentations and materials from the CAPRA 2024 Pharmaceutical Symposium. This year’s event brought together regulatory professionals, industry leaders, and innovators to explore the latest advancements, challenges, and trends shaping the pharmaceutical landscape. Whether you attended the symposium or are catching up, these resources offer valuable insights, expert perspectives, and practical takeaways that will help drive excellence in regulatory affairs and beyond. Dive into the comprehensive content that will keep you informed and ahead in your field.

Karen Reynolds

Director General, Pharmaceutical Drugs Directorate (PDD),
Health Canada

PRESENTATION

Opening Remarks

Krisitin Williamson

Director General, Pharmaceutical Drugs Directorate (PDD),
Health Canada

PRESENTATION

Canadian Generic Pharmaceutical Association (CGPA) Overview 

Lama Abi Khaled

Executive Director, Ethics, Legal and Regulatory,
Innovative Medicines Canada

PRESENTATION

Innovative Medicines Canada (IMC) Overview

Chris Rose

Director, Bureau of Pharmaceutical Sciences, PDD, 
Health Canada

PRESENTATION

Updates from the Bureau of Pharmaceutical Sciences

Dr. Susan Lum

Generic Drug Quality Division Manager, PDD,
Health Canada.

PRESENTATION

Negative Decision Analysis

Veronica Yip

Labelling Division Manager, Pharmaceutical Drugs Directorate (PDD),
Health Canada

PRESENTATION

Labelling Deficiencies Observed in Drug Submissions

Stephanie Di Trapani 

Director of the Operations Division, Health Products Shortages Directorate,
Health Canada

PRESENTATION

Comprehensive Drug Shortage Update

Mina Tadrous

An Assistant Professor at the Leslie Dan Faculty of Pharmacy,

University of Toronto

PRESENTATION

Comprehensive Drug Shortage Update

Stephen Horne

Senior Scientific Evaluator/Nitrosamine Subject Matter Expert, Quality Risk Management and Operations Division, BPS, PDD
Health Canada.

PRESENTATION

Latest Nitrosamines Update

Alisa Vespa

Senior Scientific Evaluator/Nitrosamine Safety Subject Matter Expert, Office of Risk Management Division, BMS, PDD,
Health Canada

PRESENTATION

Latest Nitrosamines Update



Martin Ehlert

Vice President,
Global API R&D,
Apotex Inc.




PRESENTATION

Latest Nitrosamines Update


Oliver R. Thiel

Member of
EFPIA ICH M7 EWG




PRESENTATION

Latest Nitrosamines Update
(Panel)

Thank You to Our Platinum Sponsors

We would like to extend our heartfelt gratitude to the sponsors of the CAPRA 2024 Pharmaceutical Symposium. Without your generous support, events like this wouldn't be possible. Your commitment not only helps us bring together the brightest minds in the pharmaceutical and regulatory fields but also ensures the continued success of these knowledge-sharing platforms. Together, we are driving innovation, fostering collaboration, and shaping the future of the industry. Thank you for making this event a reality.

Click on our sponsors' logos to view more resources.